‌

US Patent 9925247 IL-15-based molecules and methods of use thereof

Patent 9925247 was granted and assigned to Altor BioScience on March, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent attributes

Patent Applicant

Altor BioScience

Current Assignee

Altor BioScience

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

March 27, 2018

Patent Application Number

14755989

Date Filed

June 30, 2015

Patent Citations Received

US Patent 11890323 Method of treating cancer with composition comprising IL-15-based molecules and BCG

0

US Patent 11992516 Compositions comprising IL-15-based molecules and immune checkpoint inhibitor antibodies

0

US Patent 11975059 IL-15-based fusions to IL-12 and IL-18

0

US Patent 11701408 Treatment of immunosuppressed subjects

0

US Patent 11872272 IL-15-based fusions to IL-12 and IL-18

0

US Patent 11925676 Method for treating neoplasia with an anti-CD38 antibody and an IL-15:IL-15R complex

0

Patent Primary Examiner

Bridget E Bunner

Patent abstract

The invention features combination therapies using an IL-15-based superagonist complex and an antibody to effectively treat subjects with cancer and infectious diseases.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9925247 IL-15-based molecules and methods of use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool